share_log

微創醫療：截至二零二三年十二月三十一日止年度之全年業績公告

MICROPORT: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

香港交易所 ·  Mar 28 09:08
Summary by Moomoo AI
微創醫療科學有限公司公布截至2023年12月31日止年度全年業績，收入達950.7百萬美元，較上年增加15.8%（剔除匯率影響）。毛利為532.1百萬美元，年內虧損擴大至649.2百萬美元。公司權益股東應佔虧損為477.6百萬美元。每股虧損為26.19美分。年內非香港財務報告準則經調整淨虧損為434.6百萬美元，較去年收窄13.5%。公司表示，收入增長主要得益於市場份額提升及新產品推廣，並積極控制成本，提升運營效率。未來將繼續拓展國內外市場，深化全球化戰略。
微創醫療科學有限公司公布截至2023年12月31日止年度全年業績，收入達950.7百萬美元，較上年增加15.8%（剔除匯率影響）。毛利為532.1百萬美元，年內虧損擴大至649.2百萬美元。公司權益股東應佔虧損為477.6百萬美元。每股虧損為26.19美分。年內非香港財務報告準則經調整淨虧損為434.6百萬美元，較去年收窄13.5%。公司表示，收入增長主要得益於市場份額提升及新產品推廣，並積極控制成本，提升運營效率。未來將繼續拓展國內外市場，深化全球化戰略。
Micro-Chung Medical Sciences Limited announced its annual results for the year ended December 31, 2023 with revenues of $950.7 million, an increase of 15.8% over the previous year (excluding exchange rate impact). Gross profit was $532.1 million, and the year-ago loss widened to $649.2 million. The company's equity shareholders incurred a loss of $477.6 million. Loss per share was 26.19 cents. Non-Hong Kong Financial Reporting Criteria adjusted net loss was US$434.6 million for the year, down 13.5% from last year. The company said revenue growth was mainly driven by increased market share and new product promotion, and by actively controlling costs to improve operating efficiency. In the future, we will continue to expand the domestic and foreign markets and deepen the globalization strategy.
Micro-Chung Medical Sciences Limited announced its annual results for the year ended December 31, 2023 with revenues of $950.7 million, an increase of 15.8% over the previous year (excluding exchange rate impact). Gross profit was $532.1 million, and the year-ago loss widened to $649.2 million. The company's equity shareholders incurred a loss of $477.6 million. Loss per share was 26.19 cents. Non-Hong Kong Financial Reporting Criteria adjusted net loss was US$434.6 million for the year, down 13.5% from last year. The company said revenue growth was mainly driven by increased market share and new product promotion, and by actively controlling costs to improve operating efficiency. In the future, we will continue to expand the domestic and foreign markets and deepen the globalization strategy.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more